Cancers

Jan 17, 2021| Posted in: Cancers, Hematologic Disorders, Treatment

Overview of ECHELON-1 Study for Hodgkin Lymphoma

Dr. Anna Sureda, Head of the Onco-Hematology Service…
Jan 15, 2021| Posted in: Cancers, Drug Development, News, Treatment

FDA Approves Pfizer’s Xalkori for ALCL in Children and Young Adults

The Food and Drug Administration has approved Pfizer's…
Jan 14, 2021| Posted in: Cancers, Hematologic Disorders

Overview of Hodgkin Lymphoma

Dr. Anna Sureda, Head of the Onco-Hematology Service…
Jan 10, 2021| Posted in: Cancers, Diagnosis, Endocrine Disorders, Metabolic Disorders, Musculoskeletal Diseases

Acromegaly and Pituitary Tumors

Lisa Nachtigall, MD, Clinical Director, Neuroendocrine and Pituitary…
Jan 1, 2021| Posted in: Cancers, Hematologic Disorders, Treatment

Brief Overview of CLL Treatment Landscape

Lori Leslie, MD, Assistant Professor at Hackensack Meridian…
Dec 31, 2020| Posted in: Cancers, Hematologic Disorders

Chronic Lymphocytic Leukemia Overview

Othman Al-Sawaf, MD, from the University of Cologne,…
Dec 28, 2020| Posted in: Cancers, Hematologic Disorders

Brentuximab Vedotin Continues to Provide Improvement for Peripheral T-cell Lymphoma Patients

Thanos Zomas, MD, from Takeda Oncology, discusses 5-year…

Tenosynovial Giant Cell Tumor (TGCT)

Tenosynovial giant cell tumor (TGCT) is a non-malignant tumor involving the joint synovium, bursae, and tendon sheath. These rare tumors are sometimes referred to as giant cell tumor of the tendon sheath (GCT-TS) and/or pigmented villonodular synovitis (PVNS).

Neuroendocrine Tumors (NETs) Research Highlights: CME Program

Edward M Wolin, MD from the Tisch Cancer Institute at Mount Sinai and Icahn School of Medicine at Mount Sinai, highlights the latest information about NETs and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with these rare diseases.

Cutaneous T-Cell Lymphoma Learning Center

Cutaneous T-cell lymphoma (CTCL) belongs to the non-Hodgkin lymphoma class of hematologic T-cell lymphoproliferative disorders. It is a rare group of malignancies, with an incidence of 6.4 cases per 1 million people.

Rare Disease Clinical Trials CME Program

Learn about clinical trials and rare diseases through these brief courses that are certified for CME and CNE credit.
  • Heather Lau, MD, MS, NYU School of Medicine, New York, NY
  • Morie A Gertz, MD, Mayo Clinic, Rochester, MN
  • Timothy Craig, DO, Penn State University, Hershey, PA
  • Eric T. Wong, MD, Harvard Medical School, Boston, MA

CME Program: Gaucher Disease Highlights from WORLDSymposium 2020

Neal Weinreb, MD, FACP highlights the latest information about Gaucher disease from WORLDSymposium and provides expert analysis of its clinical relevance to help health care providers better care for patients with this rare disease.

CME Program: Mucopolysaccharidoses (MPSs) Highlights from WORLDSymposium 2020

Barbara K. Burton, MD highlights the latest information about MPSs from WORLDSymposium and provides expert analysis of its clinical relevance for members of the care team in order to help them care for patients with these rare diseases.

Cancers

Topics